Continue to Site
Data scientists

The top drug discovery predictions of 2023

Pfizer and BioNTech logos

Pfizer seeks EUA for omicron booster for under-5 kids

GSK

GSK’s Jemperli fares well in interim analysis of endometrial cancer trial

Eli Lilly in the Drug Discovery & Development Pharma 50

Lilly completes acquisition of Akouos

Valneva/Pfizer

Lyme disease vaccine from Valneva and Pfizer has promising antibody persistence data 

BioNTech/Ryvu

BioNTech to partner with Polish STING agonist firm Ryvu Therapeutics

cleanroom

Increased CGT demand could fuel demand for alternative cleanroom arrangements

AWS

AWS launches Amazon Omics to sift through multiomic data

Antibody-oligonucleotide

How can we target emerging oligonucleotide therapies for success?